9hon MSN
Kidney organoids uncover Hippo signaling pathway as a therapeutic target for nephronophthisis
Using human-induced pluripotent stem cell-derived kidney organoids, researchers from Science Tokyo uncovered how abnormal ...
In this video, Anjay Rastogi, MD, PhD, professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, discusses the screening process for chronic kidney disease.
On October 7, 2025, Merck announced the completion of the Verona Pharma acquisition. Verona is now a wholly-owned subsidiary of Merck. Ohtuvayre, a first-in-class maintenance treatment for chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback